GLB1L2: Potential Drug Target Or Biomarker (G89944)

Target Name: GLB1L2

NCBI ID: G89944

GLB1L2

GLB1L2: Potential Drug Target Or Biomarker

GLB1L2 (MST114) is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the GLB1 family, which is known for its role in intracellular signaling. GLB1L2 has been shown to play a role in a variety of biological processes, including cell signaling, metabolism, and inflammation. As a result, GLB1L2 has potential as a drug target or biomarker.

One of the key functions of GLB1L2 is its role in intracellular signaling. GLB1L2 is a protein that can interact with various intracellular signaling molecules, including but not limited to: heat shock factor 1 (HSF1), heat shock factor 3 (HSF3), and neurotrophins. These molecules are involved in a variety of cellular processes, including cell signaling, metabolism, and stress response. By interacting with these molecules, GLB1L2 helps to regulate cellular processes and maintain cellular homeostasis.

GLB1L2 is also involved in the regulation of cellular metabolism. It has been shown to play a role in the metabolism of various cellular organelles, including mitochondria and endoplasmic reticulum. GLB1L2 is also involved in the regulation of cellular energy metabolism, including the metabolism of glucose and lipids. These functions are important for maintaining cellular health and are potential targets for drugs that target GLB1L2.

GLB1L2 is also involved in the regulation of cellular inflammation. It has been shown to play a role in the regulation of inflammation at the cellular level, including the regulation of pro-inflammatory cytokines. GLB1L2 is also involved in the regulation of cellular immune responses, including the regulation of T cell activity. These functions are important for maintaining cellular health and are potential targets for drugs that target GLB1L2.

In addition to its role in intracellular signaling and metabolism, GLB1L2 is also involved in the regulation of cellular adhesion. It has been shown to play a role in the regulation of cell-cell adhesion, including the regulation of tight junctions and adherens junctions. These functions are important for maintaining cellular organization and stability, and are potential targets for drugs that target GLB1L2.

GLB1L2 is also involved in the regulation of cellular signaling pathways that are important for cellular growth and survival. It has been shown to play a role in the regulation of several signaling pathways, including the TGF-β pathway and the Wnt pathway. These pathways are important for cellular growth, survival, and angiogenesis, and are potential targets for drugs that target GLB1L2.

Finally, GLB1L2 is also involved in the regulation of cellular gene expression. It has been shown to play a role in the regulation of gene expression, including the regulation of transcription and RNA post-transcription. These functions are important for maintaining cellular diversity and are potential targets for drugs that target GLB1L2.

In conclusion, GLB1L2 is a protein that is involved in a variety of cellular processes that are important for maintaining cellular health. As a result, GLB1L2 has potential as a drug target or biomarker. Further research is needed to fully understand the functions of GLB1L2 and its potential as a drug.

Protein Name: Galactosidase Beta 1 Like 2

The "GLB1L2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GLB1L2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets